130 related articles for article (PubMed ID: 38521111)
41. Circular RNA protein tyrosine kinase 2 (circPTK2) promotes colorectal cancer proliferation, migration, invasion and chemoresistance.
Jiang Z; Hou Z; Liu W; Yu Z; Liang Z; Chen S
Bioengineered; 2022 Jan; 13(1):810-823. PubMed ID: 34974791
[TBL] [Abstract][Full Text] [Related]
42. Eukaryotic initiation factor 4A2 promotes experimental metastasis and oxaliplatin resistance in colorectal cancer.
Chen ZH; Qi JJ; Wu QN; Lu JH; Liu ZX; Wang Y; Hu PS; Li T; Lin JF; Wu XY; Miao L; Zeng ZL; Xie D; Ju HQ; Xu RH; Wang F
J Exp Clin Cancer Res; 2019 May; 38(1):196. PubMed ID: 31088567
[TBL] [Abstract][Full Text] [Related]
43. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
[TBL] [Abstract][Full Text] [Related]
44.
Cheng C; Huang Z; Zhou R; An H; Cao G; Ye J; Huang C; Wu D
Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G841-G853. PubMed ID: 32146835
[TBL] [Abstract][Full Text] [Related]
45. 5-Fluorouracil dose escalation generated desensitized colorectal cancer cells with reduced expression of protein methyltransferases and no epithelial-to-mesenchymal transition potential.
Fenech K; Micallef I; Baron B
Oncol Res; 2024; 32(6):1047-1061. PubMed ID: 38827317
[TBL] [Abstract][Full Text] [Related]
46. High TrkB expression levels are associated with poor prognosis and EMT induction in colorectal cancer cells.
Fujikawa H; Tanaka K; Toiyama Y; Saigusa S; Inoue Y; Uchida K; Kusunoki M
J Gastroenterol; 2012 Jul; 47(7):775-84. PubMed ID: 22361863
[TBL] [Abstract][Full Text] [Related]
47. Loss of miR-638 in vitro promotes cell invasion and a mesenchymal-like transition by influencing SOX2 expression in colorectal carcinoma cells.
Ma K; Pan X; Fan P; He Y; Gu J; Wang W; Zhang T; Li Z; Luo X
Mol Cancer; 2014 May; 13():118. PubMed ID: 24885288
[TBL] [Abstract][Full Text] [Related]
48. Physciosporin suppresses the proliferation, motility and tumourigenesis of colorectal cancer cells.
Taş İ; Han J; Park SY; Yang Y; Zhou R; Gamage CDB; Van Nguyen T; Lee JY; Choi YJ; Yu YH; Moon KS; Kim KK; Ha HH; Kim SK; Hur JS; Kim H
Phytomedicine; 2019 Mar; 56():10-20. PubMed ID: 30668330
[TBL] [Abstract][Full Text] [Related]
49. JianPi JieDu Recipe Inhibits Epithelial-to-Mesenchymal Transition in Colorectal Cancer through TGF-
Liu X; Ji Q; Deng W; Chai N; Feng Y; Zhou L; Sui H; Li C; Sun X; Li Q
Biomed Res Int; 2017; 2017():2613198. PubMed ID: 28299321
[TBL] [Abstract][Full Text] [Related]
50. Suppression MGP inhibits tumor proliferation and reverses oxaliplatin resistance in colorectal cancer.
Huang C; Wang M; Wang J; Wu D; Gao Y; Huang K; Yao X
Biochem Pharmacol; 2021 Jul; 189():114390. PubMed ID: 33359068
[TBL] [Abstract][Full Text] [Related]
51. Paracrine Induction of Epithelial-Mesenchymal Transition Between Colorectal Cancer Cells and its Suppression by a p53/miR-192/215/NID1 Axis.
Rokavec M; Bouznad N; Hermeking H
Cell Mol Gastroenterol Hepatol; 2019; 7(4):783-802. PubMed ID: 30831320
[TBL] [Abstract][Full Text] [Related]
52. Inhibitor of DNA binding 2 knockdown inhibits the growth and liver metastasis of colorectal cancer.
Liu F; Chen S; Yu Y; Huang C; Chen H; Wang L; Zhang W; Wu J; Ye Y
Gene; 2022 Apr; 819():146240. PubMed ID: 35114275
[TBL] [Abstract][Full Text] [Related]
53. TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer.
Tang Q; Chen J; Di Z; Yuan W; Zhou Z; Liu Z; Han S; Liu Y; Ying G; Shu X; Di M
J Exp Clin Cancer Res; 2020 Nov; 39(1):232. PubMed ID: 33153498
[TBL] [Abstract][Full Text] [Related]
54. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
[TBL] [Abstract][Full Text] [Related]
55. The role of hERG1 ion channels in epithelial-mesenchymal transition and the capacity of riluzole to reduce cisplatin resistance in colorectal cancer cells.
Fortunato A
Cell Oncol (Dordr); 2017 Aug; 40(4):367-378. PubMed ID: 28593575
[TBL] [Abstract][Full Text] [Related]
56. Disheveled3 enhanced EMT and cancer stem-like cells properties via Wnt/β-catenin/c-Myc/SOX2 pathway in colorectal cancer.
Li Z; Yang Z; Liu W; Zhu W; Yin L; Han Z; Xian Y; Wen J; Tang H; Lin X; Yang Y; Wang J; Zhang K
J Transl Med; 2023 May; 21(1):302. PubMed ID: 37147666
[TBL] [Abstract][Full Text] [Related]
57. Knockdown of PYCR1 inhibits proliferation, drug resistance and EMT in colorectal cancer cells by regulating STAT3-Mediated p38 MAPK and NF-κB signalling pathway.
Yan K; Xu X; Wu T; Li J; Cao G; Li Y; Ji Z
Biochem Biophys Res Commun; 2019 Dec; 520(2):486-491. PubMed ID: 31606203
[TBL] [Abstract][Full Text] [Related]
58. A pre-existing population of ZEB2
Francescangeli F; Contavalli P; De Angelis ML; Careccia S; Signore M; Haas TL; Salaris F; Baiocchi M; Boe A; Giuliani A; Tcheremenskaia O; Pagliuca A; Guardiola O; Minchiotti G; Colace L; Ciardi A; D'Andrea V; La Torre F; Medema J; De Maria R; Zeuner A
J Exp Clin Cancer Res; 2020 Jan; 39(1):2. PubMed ID: 31910865
[TBL] [Abstract][Full Text] [Related]
59. LINC00982-encoded protein PRDM16-DT regulates
Hu HF; Han L; Fu JY; He X; Tan JF; Chen QP; Han JR; He QY
Theranostics; 2024; 14(8):3317-3338. PubMed ID: 38855188
[TBL] [Abstract][Full Text] [Related]
60. PI3K/Akt/GSK-3β signal pathway is involved in P2X7 receptor-induced proliferation and EMT of colorectal cancer cells.
Zhang WJ; Luo C; Huang C; Pu FQ; Zhu JF; Zhu ZM
Eur J Pharmacol; 2021 May; 899():174041. PubMed ID: 33737010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]